Filing Details
- Accession Number:
- 0001437749-21-027623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-01 16:05:52
- Reporting Period:
- 2021-11-30
- Accepted Time:
- 2021-12-01 16:05:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
72444 | Vaxart Inc. | VXRT | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1530193 | Margaret Echerd | C/O Vaxart, Inc. 170 Harbor Way, Suite 300 South San Francisco CA 94080 | Svp, Principal Accntng Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-30 | 666 | $5.17 | 666 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-11-30 | 2,936 | $0.77 | 3,602 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-11-30 | 3,602 | $8.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-11-30 | 666 | $0.00 | 666 | $5.17 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-11-30 | 2,936 | $0.00 | 2,936 | $0.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,667 | 2028-05-24 | No | 4 | M | Direct | |
26,416 | 2029-06-11 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of April 9, 2018, and the remaining shares in 36 equal monthly installments thereafter.
- The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.